newsfilter
← Latest News
PR Newswire·

BrainStorm Cell Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced ...